These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 8838035)
1. Somatostatin and its analogues in G.I. tract, liver and pancreatic disorders. Dhar A; Chawla YK Trop Gastroenterol; 1995; 16(3):3-7. PubMed ID: 8838035 [No Abstract] [Full Text] [Related]
2. Octreotide. Lamberts SW; van der Lely AJ; de Herder WW; Hofland LJ N Engl J Med; 1996 Jan; 334(4):246-54. PubMed ID: 8532003 [No Abstract] [Full Text] [Related]
3. [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases]. Feu F; Bosch J Gastroenterol Hepatol; 1996 Feb; 19(2):68-77. PubMed ID: 8616683 [No Abstract] [Full Text] [Related]
4. [Application of preparations--analogues of somatostatin in surgical pancreatology]. Kopchak VM; Kostylev MV; Kopchak KV; Egorova ON; Khomiak IV; Duvalko AV; Romaniv IaV; Pererva LA Klin Khir; 2008 Jan; (1):18-21. PubMed ID: 18610850 [TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine disorders of the gastroenteropancreatic system. Clinical applications of the somatostatin analogue SMS 201-995. April 2-4, 1986, San Diego, California. Am J Med; 1986 Dec; 81(6B):1-101. PubMed ID: 2879445 [No Abstract] [Full Text] [Related]
6. Potential gastrointestinal uses of somatostain and its synthetic analogue octreotide. Grosman I; Simon D Am J Gastroenterol; 1990 Sep; 85(9):1061-72. PubMed ID: 1975156 [TBL] [Abstract][Full Text] [Related]
7. Somatostatin analogues reduce liver volume in polycystic liver disease. van Keimpema L; de Man RA; Drenth JP Gut; 2008 Sep; 57(9):1338-9. PubMed ID: 18719151 [No Abstract] [Full Text] [Related]
8. Somatostatin and the gastrointestinal tract. Tulassay Z Scand J Gastroenterol Suppl; 1998; 228():115-21. PubMed ID: 9867121 [TBL] [Abstract][Full Text] [Related]
9. [Somatostatin in the treatment of pancreatic diseases]. Németh AM Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869 [TBL] [Abstract][Full Text] [Related]
10. [Somatostatin and octreotide in therapy of gastrointestinal diseases]. Stöckmann F Z Gastroenterol Verh; 1991 Mar; 26():166-70. PubMed ID: 1714136 [No Abstract] [Full Text] [Related]
11. [Biotherapy of neuroendocrine tumours of the gastrointestinal tract and pancreas]. Hansen CP; Knigge U Ugeskr Laeger; 2008 Jun; 170(24):2145-8. PubMed ID: 18565299 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders. Masclee AA; Jansen JB; Lamers CB Neth J Med; 1991 Dec; 39(5-6):356-65. PubMed ID: 1687076 [No Abstract] [Full Text] [Related]
13. Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders. Friess H; Büchler MW Digestion; 1996; 57 Suppl 1():97-102. PubMed ID: 8813484 [TBL] [Abstract][Full Text] [Related]
14. [Medical treatment of intestinal hemorrhage in portal hypertension]. Sauerbruch T; Schiedermaier P Dtsch Med Wochenschr; 1998 May; 123(20):633-6. PubMed ID: 9627572 [No Abstract] [Full Text] [Related]
15. Use of somatostatin and its long-acting analogue, octreotide, in the treatment of pancreatic diseases. Delmont J; Hastier P; Dumas R Aliment Pharmacol Ther; 1995 Oct; 9(5):581-3. PubMed ID: 8580282 [No Abstract] [Full Text] [Related]
16. Can somatostatin derivatives really be suggested in the treatment of chylothorax? Bernet-Buettiker V Pediatr Crit Care Med; 2007 May; 8(3):308; author reply 308-9. PubMed ID: 17496524 [No Abstract] [Full Text] [Related]
17. Octreotide and enterocutaneous fistula closure in neonates and children. Carrera-Guermeur N; Martín-Crespo RM; Ramírez HJ; Pantoja Á; Luque-Mialdea R Eur J Pediatr; 2016 Mar; 175(3):305-12. PubMed ID: 26811298 [TBL] [Abstract][Full Text] [Related]
18. [Effect of enzyme therapy on food tolerance and digestive disorders]. Gullatz P Landarzt; 1968 Nov; 44(33):1635-8. PubMed ID: 5717136 [No Abstract] [Full Text] [Related]
19. [Efficacy of somatostatin and its analogues in the treatment of acute pancreatitis: clinical retrospective study]. Citone G; Perri S; Nardi M; Maira E; Lotti R; Gabbrielli F; Antonellis M; Orsini S G Chir; 2001 Apr; 22(4):139-49. PubMed ID: 11370223 [TBL] [Abstract][Full Text] [Related]
20. Chronic octreotide therapy can induce pancreatic insufficiency: a common but under-recognized adverse effect. Saif MW; Larson H; Kaley K; Shaib W Expert Opin Drug Saf; 2010 Nov; 9(6):867-73. PubMed ID: 20662741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]